NSCLC Adjuvant Targeted Therapy

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
10:25

Yale Cancer Center

Key NSCLC Trial Updates Including ADAURA and KEYNOTE-671

FEATURING Sarah Goldberg
  • 89 views
  • October 21, 2024
  • 1
21:50

David Carbone

Multidisciplinary Panel Discussion: New Treatment Options for Surgically Resectable NSCLC

FEATURING Brendon Stiles
  • 375 views
  • October 21, 2024
  • 5
08:48

Insights from 2024 WCLC

WCLC 2024 Insights: The Global TRUST-II Study - Efficacy & Safety of Taletrectinib in Patients With ROS1+ NSCLC

FEATURING Geoffrey Liu
  • 38 views
  • October 11, 2024
26:38

University of Colorado Cancer Center

Metastatic EGFRm NSCLC: 1L Therapy Options

FEATURING Tejas Patil
  • 543 views
  • October 11, 2024
  • 7
08:35

Robert Hsu

Patient Selection for Targeted Therapy in BRAF V600E NSCLC

  • 172 views
  • September 26, 2024
08:02

Insights from 2024 WCLC

WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Therapy for NSCLC - Rational Targeted Combinations

FEATURING Melina Marmarelis
  • 113 views
  • September 23, 2024
  • 1
17:31

Nagla Abdel Karim

Efficacy and Safety of Encorafenib & Binimetinib in BRAF V600-Mutant NSCLC: Insights From the PHAROS Trial and Implications for Clinical Practice

  • 103 views
  • September 18, 2024
  • 1
10:25

MI&T Congressi

RET Inhibitors in NSCLC

FEATURING Benjamin Besse
  • 35 views
  • September 11, 2024
14:22

Integrity CE

Management of mNSCLC Without Actionable Mutations

FEATURING Megan Baumgart, Stephen Liu
  • 147 views
  • September 3, 2024
  • 2
09:40

MI&T Congressi

Potential Role of ADC in Early Stage NSCLC

FEATURING Enriqueta Felip
  • 35 views
  • September 3, 2024
13:51

MI&T Congressi

ADC as Targeted Therapy in NSCLC

FEATURING Fred Hirsch
  • 124 views
  • September 3, 2024
  • 1
11:40

MI&T Congressi

New Drugs for HER2 Deregulated NSCLC

FEATURING Egbert Smit
  • 62 views
  • September 3, 2024
08:38

MI&T Congressi

Options for Osimertinib-Resistant NSCLC

FEATURING Trever Bivona
  • 215 views
  • September 3, 2024
  • 4
03:34

Umberto Malapelle

BRAF as a Positive Predictive Biomarker in NSCLC

  • 77 views
  • August 28, 2024
  • 1
13:31

Fred Hutchinson Cancer Center

Practical Guidelines on Testing & Treatment of BRAF V600+ NSCLC

FEATURING Christina Baik
  • 106 views
  • August 28, 2024
  • 1
24:51

University of Miami Sylvester Comprehensive Cancer Center

An Update on Lung Cancer Targeted Therapies: The Evolution of Personalized Medicine in NSCLC

FEATURING Estelamari Rodriguez
  • 520 views
  • August 27, 2024
  • 8
10:10

MI&T Congressi

Pharmacology of ADC Classes in Lung Cancer

FEATURING Marzia Del Re
  • 98 views
  • August 27, 2024
  • 1
11:48

MI&T Congressi

ADC in Pretreated NSCLC

FEATURING Noemi Reguart Aransay
  • 53 views
  • August 27, 2024
06:46

Nebraska Oncology Society

ASCO® 2024 Review: Treatment Updates on Locally Advanced EGFR-Mutated NSCLC

FEATURING Vincent Lam
  • 42 views
  • August 13, 2024
22:08

Integrity CE

How the Experts Treat: Early Stage NSCLC With Curative Intent

FEATURING Stephen Liu
  • 151 views
  • August 8, 2024
07:54

ecancer

Best of ASCO® 2024: ADCs in NSCLC

FEATURING Edgardo Santos​
  • 98 views
  • August 8, 2024
  • 1
08:06

ecancer

Best of ASCO® 2024: Uncommon Genetic Aberrations in Advanced NSCLC - NTRK, RET, NRG

FEATURING Luis Raez
  • 37 views
  • August 8, 2024
  • 1
11:59

MI&T Congressi

How the Experts Manage: ADC-Associated Toxicities in NSCLC

FEATURING Natasha Leighl
  • 183 views
  • August 8, 2024
09:24

Frank Griesinger

Comparative Analysis of PFS & OS in 1L Treatment With Tepotinib vs. 1L IO+Chemo or IO Mono for METex14 Skipping NSCLC

  • 129 views
  • August 2, 2024
  • 1
55:10

University of Colorado Cancer Center

History of Cancer and Its Treatment: What Will It Take to Cure?

FEATURING Christopher Lieu
  • 349 views
  • August 2, 2024
  • 4

NSCLC Adjuvant Targeted Therapy

No subtopics